Clinical Trial Update: Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating pharmacokinetic interaction between nevirapine, abacavir, and amprenavir in HIV-1 infected NNRTI-naive adults; the study was terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Agenerase (amprenavir)
• Viramune (Nevirapine)
• Ziagen (Abacavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 1 | Status: TERMINATED